216 related articles for article (PubMed ID: 2450026)
1. A comparison of the long-term effects of sotalol and atenolol on QT interval and arrhythmias after myocardial infarction.
Cobbe SM; Alexopoulos D; Winner SJ; McCaie CP; Cobbe PC; Johnston J
Eur Heart J; 1988 Jan; 9(1):24-31. PubMed ID: 2450026
[TBL] [Abstract][Full Text] [Related]
2. The influence of atenolol and propafenone on QT interval dispersion in patients 3 months after myocardial infarction.
Puljevic D; Smalcelj A; Durakovic Z; Goldner V
Int J Clin Pharmacol Ther; 1997 Sep; 35(9):381-4. PubMed ID: 9314091
[TBL] [Abstract][Full Text] [Related]
3. [Ventricular tachyarrhythmia induced by low doses of sotalol: torsade de pointes or polymorphous ventricular tachycardia?].
Ophoff N; Toker Y
Z Kardiol; 1988 Jun; 77(6):393-7. PubMed ID: 3213144
[TBL] [Abstract][Full Text] [Related]
4. Sotalol.
Hohnloser SH; Woosley RL
N Engl J Med; 1994 Jul; 331(1):31-8. PubMed ID: 8202100
[TBL] [Abstract][Full Text] [Related]
5. Randomized double blind trial comparing sotalol and propranolol in chronic ventricular arrhythmia.
Kubac G; Klinke WP; Grace M
Can J Cardiol; 1988 Oct; 4(7):355-9. PubMed ID: 3067834
[TBL] [Abstract][Full Text] [Related]
6. Multicentre randomized trial of sotalol vs amiodarone for chronic malignant ventricular tachyarrhythmias. Amiodarone vs Sotalol Study Group.
Eur Heart J; 1989 Aug; 10(8):685-94. PubMed ID: 2676535
[TBL] [Abstract][Full Text] [Related]
7. [Serial changes in QT interval during acute myocardial infarction: comparison of QT interval changes of reperfused cases and non-reperfused cases].
Niwa H; Maeda T; Shimoyama N; Tenda K; Yonemochi H; Saikawa T; Takaki R; Fukuoka Y; Inoue K; Hara M
J Cardiol; 1993; 23(1):41-50. PubMed ID: 8164133
[TBL] [Abstract][Full Text] [Related]
8. [Effect of atenolol on the QT interval in the acute phase of myocardial infarction].
Rynkiewicz A; Rossi P; Yusuf S; Sleight P
Kardiol Pol; 1988; 31(8):505-9. PubMed ID: 3072436
[No Abstract] [Full Text] [Related]
9. Concurrent supplement of estradiol and progesterone reduces the cardiac sensitivity to D,L-sotalol-induced arrhythmias in ovariectomized rabbits.
Cheng J; Su D; Ma X; Li H
J Cardiovasc Pharmacol Ther; 2012 Jun; 17(2):208-14. PubMed ID: 21875897
[TBL] [Abstract][Full Text] [Related]
10. Short QT syndrome: pharmacological treatment.
Gaita F; Giustetto C; Bianchi F; Schimpf R; Haissaguerre M; Calò L; Brugada R; Antzelevitch C; Borggrefe M; Wolpert C
J Am Coll Cardiol; 2004 Apr; 43(8):1494-9. PubMed ID: 15093889
[TBL] [Abstract][Full Text] [Related]
11. [Amiodarone therapy after sotalol-induced torsade de pointes: prolonged QT interval and QT dispersion in differentiation of pro-arrhythmic effects].
van de Loo A; Klingenheben T; Hohnloser SH
Z Kardiol; 1994 Dec; 83(12):887-90. PubMed ID: 7846927
[TBL] [Abstract][Full Text] [Related]
12. Stress/catecholamine-induced cardiac necrosis. Reduction by beta 1-selective blockade.
Cruickshank JM; Neil-Dwyer G; Hayes Y; Degaute JP; Kuurne T; Kytta J; Carruthers ME; Patel S
Postgrad Med; 1988 Feb; Spec No():140-7. PubMed ID: 2831524
[TBL] [Abstract][Full Text] [Related]
13. QT dispersion as a predictor of long-term mortality in patients with acute myocardial infarction and clinical evidence of heart failure.
Spargias KS; Lindsay SJ; Kawar GI; Greenwood DC; Cowan JC; Ball SG; Hall AS
Eur Heart J; 1999 Aug; 20(16):1158-65. PubMed ID: 10448024
[TBL] [Abstract][Full Text] [Related]
14. QT dispersion and early arrhythmic risk during acute myocardial infarction.
Ciolli A; Di Lorenzo M; Bevilacqua U; Lo Sardo G; Tripi M; Fidati R; Palamara A
G Ital Cardiol; 1999 Dec; 29(12):1438-44. PubMed ID: 10687106
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological mechanisms of action of the levorotatory isomer of sotalol in a canine infarct model of inducible ventricular tachycardia: comparison with the beta-1 receptor antagonist bisoprolol.
Aidonidis I; Rizos I; Hilbel T; Kuebler W; Brachmann J
J Mol Cell Cardiol; 1994 Jul; 26(7):841-8. PubMed ID: 7966352
[TBL] [Abstract][Full Text] [Related]
16. [QT time and the ventricular refractory period in programmed electrical stimulation of the heart in patients with ventricular and supraventricular tachycardias--effect of sotalol].
Wehr M
Z Kardiol; 1986 Dec; 75(12):744-50. PubMed ID: 3825224
[TBL] [Abstract][Full Text] [Related]
17. Frequency and prognostic significance of QT prolongation in chronic renal failure patients.
Voiculescu M; Ionescu C; Ismail G
Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617
[TBL] [Abstract][Full Text] [Related]
18. Sotalol-induced prolongation of the Q-T interval and attacks of unconsciousness.
Laakso M; Pentikäinen PJ; Rehnberg S
Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):487-90. PubMed ID: 6500767
[TBL] [Abstract][Full Text] [Related]
19. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
20. QT dispersion and early arrhythmic risk in acute myocardial infarction.
Mulay DV; Quadri SM
Indian Heart J; 2004; 56(6):636-41. PubMed ID: 15751519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
